Niagen Bioscience, Inc., a Los Angeles-based company specializing in NAD+ (nicotinamide adenine dinucleotide) research and its applications in healthy aging, has appointed Abhijit Kale, Ph.D., as senior director of global external research. In this role, Dr. Kale will manage the company’s Global Niagen Research Program and oversee its international network of academic and clinical research partnerships.

Dr. Kale will be responsible for guiding Niagen Bioscience’s scientific research strategy and collaborating with leading investigators to advance understanding of NAD+ biology, as well as its implications for healthy aging and age-related health conditions. His appointment is expected to strengthen the company’s position in the field of NAD+ research.